Drug Approval
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
Santhera, ReveraGen’s Duchenne Drug Accepted By EMA While Anticipating FDA Priority Review
2022-11-01
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25